This result confirms that the high anticancer activity of KCC-NH2-FA-CR may be also indirectly related to its ability to down regulate c-MET in HepG2 cells, where the MCL-1 is the key protein for tumor survival. The gene discussed is MCL1; the disease is neoplasm.